BeOne Medicines
ONC
#652
Rank
NZ$61.68 B
Marketcap
NZ$557.45
Share price
-2.56%
Change (1 day)
56.77%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

Market capitalization of BeOne Medicines (ONC)

Market cap: NZ$61.68 Billion

As of December 2025 BeOne Medicines has a market cap of NZ$61.68 Billion. This makes BeOne Medicines the world's 652th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of BeOne Medicines from 2016 to 2025

End of year Market Cap

Year Marketcap Change
2025NZ$61.68 B69.87%
2024NZ$36.31 B16.5%
2023NZ$31.17 B-22.18%
2022NZ$40.05 B-1.55%
2021NZ$40.68 B24.04%
2020NZ$32.80 B116.22%
2019NZ$15.17 B21.77%
2018NZ$12.45 B98.83%
2017NZ$6.26 B260.33%
2016NZ$1.73 B

End of Day market cap according to different sources

On Dec 7th, 2025 the market cap of BeOne Medicines was reported to be:

NZ$61.68 Billion
by Nasdaq info icon info icon
NZ$61.68 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Onconova Therapeutics
ONTX
NZ$36.08 M-99.94%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
NZ$1.83 B-97.02%๐Ÿ‡บ๐Ÿ‡ธ USA